Joellen C Speca, MD | |
4420 Lake Boone Trl, Suite 200, Raleigh, NC 27607-7505 | |
(919) 784-6818 | |
(919) 784-6826 |
Full Name | Joellen C Speca |
---|---|
Gender | Female |
Speciality | Hematology/oncology |
Experience | 23 Years |
Location | 4420 Lake Boone Trl, Raleigh, North Carolina |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013180108 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | (North Carolina) | Secondary |
207RH0003X | Internal Medicine - Hematology & Oncology | (North Carolina) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Rex Hospital | Raleigh, NC | Hospital |
University Of North Carolina Hospital | Chapel hill, NC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Rex Hospital Inc | 0840109864 | 652 |
News Archive
Bristol-Myers Squibb Company and Pharmasset announced today that the companies have entered into a clinical collaboration agreement to evaluate the utility of BMS-790052, Bristol-Myers Squibb's NS5A replication complex inhibitor, in combination with PSI-7977, Pharmasset's nucleotide polymerase inhibitor, for the treatment of chronic hepatitis C virus.
In light of World Asthma Day, News-Medical interviewed Dr. Samantha Walker from Asthma UK and the British Lung Foundation about fighting asthma in 2021.
Researchers at the David Geffen School of Medicine at UCLA have solved the structure of a class of proteins known as sodium glucose co-transporters (SGLTs), which pump glucose into cells.
Xencor, Inc., a company using its proprietary Protein Design Automation (PDA) platform technology to engineer next-generation antibodies, and Boehringer Ingelheim announced today a collaboration agreement for certain Xencor biosuperior monoclonal antibodies.
› Verified 5 days ago
Entity Name | Rex Hospital Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1144248683 PECOS PAC ID: 0840109864 Enrollment ID: O20140613001181 |
News Archive
Bristol-Myers Squibb Company and Pharmasset announced today that the companies have entered into a clinical collaboration agreement to evaluate the utility of BMS-790052, Bristol-Myers Squibb's NS5A replication complex inhibitor, in combination with PSI-7977, Pharmasset's nucleotide polymerase inhibitor, for the treatment of chronic hepatitis C virus.
In light of World Asthma Day, News-Medical interviewed Dr. Samantha Walker from Asthma UK and the British Lung Foundation about fighting asthma in 2021.
Researchers at the David Geffen School of Medicine at UCLA have solved the structure of a class of proteins known as sodium glucose co-transporters (SGLTs), which pump glucose into cells.
Xencor, Inc., a company using its proprietary Protein Design Automation (PDA) platform technology to engineer next-generation antibodies, and Boehringer Ingelheim announced today a collaboration agreement for certain Xencor biosuperior monoclonal antibodies.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Joellen C Speca, MD 4420 Lake Boone Trl, Suite 200, Raleigh, NC 27607-7505 Ph: (919) 784-6818 | Joellen C Speca, MD 4420 Lake Boone Trl, Suite 200, Raleigh, NC 27607-7505 Ph: (919) 784-6818 |
News Archive
Bristol-Myers Squibb Company and Pharmasset announced today that the companies have entered into a clinical collaboration agreement to evaluate the utility of BMS-790052, Bristol-Myers Squibb's NS5A replication complex inhibitor, in combination with PSI-7977, Pharmasset's nucleotide polymerase inhibitor, for the treatment of chronic hepatitis C virus.
In light of World Asthma Day, News-Medical interviewed Dr. Samantha Walker from Asthma UK and the British Lung Foundation about fighting asthma in 2021.
Researchers at the David Geffen School of Medicine at UCLA have solved the structure of a class of proteins known as sodium glucose co-transporters (SGLTs), which pump glucose into cells.
Xencor, Inc., a company using its proprietary Protein Design Automation (PDA) platform technology to engineer next-generation antibodies, and Boehringer Ingelheim announced today a collaboration agreement for certain Xencor biosuperior monoclonal antibodies.
› Verified 5 days ago
Dr. William Brooks Hall, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2605 Blue Ridge Rd Ste 190, Raleigh, NC 27607 Phone: 919-784-7460 | |
Dr. Serdal Aktolga, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3000 New Bern Ave, Raleigh, NC 27610 Phone: 919-350-8000 Fax: 919-350-7204 | |
Sheila A Munday, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3101 John Humphries Wynd, Raleigh, NC 27612 Phone: 919-881-8272 Fax: 919-881-2026 | |
Dr. James Robert Foster, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 3000 New Bern Ave, G-100, Raleigh, NC 27610 Phone: 919-231-8253 Fax: 919-231-9546 | |
Dr. Michael Joseph Casey, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3604 Bush St, 2nd Floor, Raleigh, NC 27609 Phone: 919-876-7807 Fax: 919-876-8823 | |
Adnan Pervez, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2605 Blue Ridge Rd Ste 190, Raleigh, NC 27607 Phone: 919-784-7460 Fax: 919-784-5698 | |
Dr. Morgan Eileen Mullaney, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4420 Lake Boone Trl Ste 420, Raleigh, NC 27607 Phone: 919-784-3100 |